Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
31.95
+0.01 (0.03%)
At close: Jan 29, 2025, 4:00 PM
31.00
-0.95 (-2.97%)
After-hours: Jan 29, 2025, 5:12 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $18.82 billion as of January 29, 2025. Its market cap has increased by 47.90% in one year.
Market Cap
18.82B
Enterprise Value
25.43B
1-Year Change
47.90%
Ranking
Category
Stock Price
$31.95
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $18.82B, an increase of 19.44%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2025 | 14.19B | 25.21% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.70B |
| UnitedHealth Group | 500.19B |
| Novo Nordisk | 389.08B |
| Johnson & Johnson | 368.10B |
| AbbVie | 312.61B |
| Merck & Co. | 247.75B |
| Abbott Laboratories | 224.49B |
| Thermo Fisher Scientific | 223.24B |